In our efforts to expand across the country @ACVIM is one of the best conferences that we attend as an exhibitor. We have made some incredible veterinarians across the country interested in our innovative, targeted radiation cancer treatment! $RDGL
Vivos Inc is pleased to announce the receipt of the Washington State Radioactive Materials License for IsoPet® Manufacturing which clears the way for in-house production at Vivos’ new domestic manufacturing facility. $RDGLglobenewswire.com/news-relea…
Vivos Inc. (OTCQB: RDGL) submits Early Feasibility Investigational Device Exemption (IDE) application to the U.S. Food and Drug Administration (FDA) for RadioGel® Precision Radionuclide Therapy™ $RDGLglobenewswire.com/news-relea…
We are pleased to announce an update to our website! An abstract and presentation from
Johns Hopkins University on the Utilization of Radiopharmaceutical Therapies in Animals with Naturally Occurring Disease. $RDGLisopet.com/resources/
Vivos Inc. is pleased to announce the completed enrollment in a 20 patient clinical study for our IsoPet® Postoperative Precision Radionuclide Therapy for Incomplete Tumor Resection. To read the full statement visit vivosinc.com/business-update…
This sweet girl was diagnosed with oral cancer, and thanks to the expertise of Dr. Diana Sanchez at NorthStar VETS, she received IsoPet® Margin Therapy following surgery—targeting the tumor bed to help eliminate any remaining cancer cells. $RDGL
Another successful IsoPet® treatment of a Mast cell tumor which is one of the most common skin cancers affecting 15-25% of all canine skin tumors. Thank you to Dr. Sanchez of NorthStarVets in Robbinsville, NJ for saving Anu’s life! $RDGL
Capital Veterinary Specialists just broke the record for pets treated in one day by successfully treating 8 patients with IsoPet® Precision Radionuclide Therapy™. CVS is using a new Margin Therapy protocol to expand treatment options for cancer care. $RDGL
Our animal cancer division @IsoPetForCancer is pleased to report continued growth for Q1 that will be further highlighted in the upcoming 10Q. Thank you for following our journey to treating cancer a safer and more effective way. $RDGL
A press release was issued today to summarize the incredible progress of our animal cancer division @IsoPetForCancer signaling growing awareness and demand for this precise, cost-effective alternative to traditional radiation. $RDGLglobenewswire.com/news-relea…
2025 marked a major commercialization milestone for IsoPet® Animal Cancer Division. The number of certified clinics more than doubled, expanding from 8 locations in 2024 to 17 by year-end 2025—clear evidence of accelerating adoption and growing demand. $RDGL
Today is a day to recognize our vets and a perfect time to give a little shout-out to all those forward-thinking vets out there that have come on board with us in 2025 to offer their patients a safer cancer treatment option with IsoPet®
Soft tissue sarcoma is something our vets see often, and it can be unsettling for any pet parent. We put together an easy to follow blog that explains the signs and symptoms so you can stay informed without feeling overwhelmed.
isopet.com/a-guide-to-unders…
Our new website has launched! IsoPet® is a safer cancer treatment for small and large animals with clinics across the USA. Visit our new website for more details! $RDGLisopet.com/
We want to recognize the dedicated and brilliant team working behind the scenes to bring Vivos Inc’s vision to life. Our divisions @RadioGel and @IsoPetForCancer are pushing forward to offer safe and effective treatments for cancer worldwide. $RDGL
2018–2024 we established our technical groundwork for Precision Radionuclide Therapy™ in veterinary care.
2025 is IsoPet’s first operational year as its own division, saving more pets from cancer.
2026 we will implement profitability-focused initiatives.
In 2025 IsoPet® was driven by a simple goal: give pets fighting cancer a better chance. By working with compassionate leaders like Dr. Drygas and Dr. Jehn at CVS, who embrace new technology, we’re giving pets living with cancer new hope. $RDGL